Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03721835 · ClinicalTrials.gov registry record · NA

Safety Study of Femoral Neck Fracture System

A NA study, sponsored by Smith & Nephew.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT03721835: Clinical Trial NA study, sponsored by Smith & Nephew.

NCT03721835 is a NA study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03721835, a NA study, was terminated before completion, sponsored by Smith & Nephew.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to assess the reoperation rate of fractures that have occurred at the neck of the femur that are treated with the CONQUEST FN Femoral Neck Fracture System. The CONQUEST FN Femoral Neck Fracture System is approved for use by the United States Food and Drug Administration (FDA). It consists of a stainless steel plate and up to three (3) screws intended to treat both non-displaced and displaced fractures to the femoral neck.

Primary Outcome

Reoperation for any reason from time of implantation to one-year post operation

Interventions

  • DEVICE CONQUEST FN Femoral Neck Fracture System

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-09-10
Est. Completion 2020-02-11
Phase NA
Smith & Nephew

72 total trials

Why NCT03721835 stopped before completion

NCT03721835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which CONQUEST FN Femoral Neck Fracture System is the first listed.

NCT03721835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03721835 about?

NCT03721835 is a clinical study titled "Safety Study of Femoral Neck Fracture System". The purpose of this study is to assess the reoperation rate of fractures that have occurred at the neck of the femur that are treated with the CONQUEST FN Femoral Neck Fracture System. The CONQUEST FN Femoral Neck Fracture System is approved for use by the United States Food and Drug Administration ...

What is the current status of trial NCT03721835?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2018-09-10. Estimated completion is 2020-02-11.

What interventions are being tested in trial NCT03721835?

The interventions under investigation include: CONQUEST FN Femoral Neck Fracture System (DEVICE).

Who is sponsoring clinical trial NCT03721835?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03721835's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03721835, the US trial registry maintained by the National Library of Medicine. NCT03721835 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.